Macromoltek Inc Company
Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics. This mother-daughter team’s approach aims to make research for everything from flu to cancer treatments an order of magnitude faster. With an accelerated process to discover antibodies, medical researchers can (1) craft targeted treatment plans for previously undruggable targets and (2) overcome patients’ drug resistance, a major challenge when treating diseases caused by bacteria, viruses, and parasites.
Funding Status:
private
Total Funding:
1492194
Industry:
Quantum Chemistry
Founded Date:
2010-01-01
Last Funding Date:
2018-01-01
Headquarters:
Austin,Texas,United States,North America
Employee Number:
11-50
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
1492194
Last Funding Total Usd:
120000
Last Funding Total Currency:
USD
Last Funding Total Value:
120000
Founders:
Monica Berrondo,Susana Kaufmann